amifampridine phosphate

FDA Drug Profile — Firdapse

Drug Details

Generic Name
amifampridine phosphate
Brand Names
Firdapse
Application Number
NDA208078
Sponsor
Patheon Pharmaceuticals Inc.
NDC Codes
3
Dosage Forms
TABLET, POWDER
Routes
ORAL
Active Ingredients
AMIFAMPRIDINE PHOSPHATE

Indications and Usage

1 INDICATIONS AND USAGE FIRDAPSE ® is indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults and pediatric patients 6 years of age and older. FIRDAPSE is a potassium channel blocker indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults and pediatric patients 6 years of age and older. ( 1 )